Observational Study, Use of Canakinumab Administered Subcutaneously in the Treatment COVID-19 Pneumonia

NCT04348448 · clinicaltrials.gov ↗
TERMINATED
Status
100
Enrollment
OTHER
Sponsor class

Stopped due to covid

Conditions

Interventions

Sponsor

AUSL Romagna Rimini